Innovative Industrial Properties (IIPR) Q4 2024 earnings summary

Executive summary

• Generated $308.5 million in 2024 revenue, with over $255 million in cash flow from operations and $210 million returned to shareholders via dividends, maintaining annual dividend increases since 2016.

• Net income attributable to common stockholders was $159.9 million ($5.52 per share) for 2024, reflecting a modest decline from 2023.

• Deployed over $70 million in capital for property acquisitions and facility enhancements, executing new leases at six properties covering 530,000 sq ft.

• Strengthened liquidity with an upsized credit facility to $87.5 million and total available liquidity exceeding $235 million at year-end.

• Achieved a comprehensive resolution with PharmaCann, including recommencement of rent payments, a junior secured note, and property transitions.

Financial highlights

• Total revenues for 2024 were $308.5 million, nearly flat compared to $309.5 million in 2023, with Q4 revenues at $76.7 million.

• AFFO for 2024 was $256.1 million ($8.98/share); Q4 AFFO was $63.4 million ($2.22/share), down 3% year-over-year and 1% sequentially.

• Net income per share for Q4 2024 declined 6% year-over-year; AFFO payout ratio for Q4 was 86%.

• Applied $5.7 million in security deposits for contractually due rent in Q4, with $4.3 million related to PharmaCann.

• Received a $3.9 million lease termination fee from a property sale in Los Angeles.

Outlook and guidance

• Management remains optimistic about industry growth, citing BDSA projections of 10% U.S. cannabis sales growth in 2025 and continued state-level legalization momentum.

• Cautiously optimistic on federal reform, with attention on potential rescheduling and SAFE Banking progress.

• Pipeline for 2025 remains opportunistic and disciplined, with $7.8 million under contract and strong liquidity to pursue further investments.